152 related articles for article (PubMed ID: 32718287)
1. Single Nucleotide Polymorphisms in Colitis-Associated Colorectal Cancer: A Current Overview with Emphasis on the Role of the Associated Genes Products.
Makaro A; Fichna J; Włodarczyk M
Curr Drug Targets; 2020; 21(14):1456-1462. PubMed ID: 32718287
[TBL] [Abstract][Full Text] [Related]
2. Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis.
Li H; Jin Z; Li X; Wu L; Jin J
Clin Transl Oncol; 2017 Aug; 19(8):1018-1027. PubMed ID: 28243990
[TBL] [Abstract][Full Text] [Related]
3. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer.
Rajamäki K; Taira A; Katainen R; Välimäki N; Kuosmanen A; Plaketti RM; Seppälä TT; Ahtiainen M; Wirta EV; Vartiainen E; Sulo P; Ravantti J; Lehtipuro S; Granberg KJ; Nykter M; Tanskanen T; Ristimäki A; Koskensalo S; Renkonen-Sinisalo L; Lepistö A; Böhm J; Taipale J; Mecklin JP; Aavikko M; Palin K; Aaltonen LA
Gastroenterology; 2021 Aug; 161(2):592-607. PubMed ID: 33930428
[TBL] [Abstract][Full Text] [Related]
4. Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms.
Connelly TM; Berg AS; Harris LR; Brinton DL; Hegarty JP; Deiling SM; Stewart DB; Koltun WA
Surgery; 2014 Aug; 156(2):253-62. PubMed ID: 24947639
[TBL] [Abstract][Full Text] [Related]
5. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
[TBL] [Abstract][Full Text] [Related]
6. Colitis-Associated Colorectal Cancer Survival is Comparable to Sporadic Cases after Surgery: a Matched-Pair Analysis.
Raje P; Sonal S; Qwaider YZ; Sell NM; Stafford CE; Boudreau C; Schneider D; Ike A; Kunitake H; Berger DL; Ricciardi R; Bordeianou LG; Cauley CE; Lee GC; Goldstone RN
J Gastrointest Surg; 2023 Jul; 27(7):1423-1428. PubMed ID: 37165158
[TBL] [Abstract][Full Text] [Related]
7. Regulation of MicroRNAs in Inflammation-Associated Colorectal Cancer: A Mechanistic Approach.
Muthusami S; Ramachandran I; Krishnamoorthy S; Sambandam Y; Ramalingam S; Queimado L; Chaudhuri G; Ramachandran IK
Endocr Metab Immune Disord Drug Targets; 2021; 21(1):67-76. PubMed ID: 32940190
[TBL] [Abstract][Full Text] [Related]
8. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
Azer SA
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
[TBL] [Abstract][Full Text] [Related]
9. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.
Yashiro M
Dig Dis Sci; 2015 Aug; 60(8):2251-63. PubMed ID: 25840920
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?
Andersen V; Halfvarson J; Vogel U
World J Gastroenterol; 2012 Aug; 18(31):4091-4. PubMed ID: 22919240
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer.
James JP; Riis LB; Malham M; Høgdall E; Langholz E; Nielsen BS
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114313
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer in patients with inflammatory bowel disease.
Vagefi PA; Longo WE
Clin Colorectal Cancer; 2005 Jan; 4(5):313-9. PubMed ID: 15663834
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
Itzkowitz SH; Yio X
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G7-17. PubMed ID: 15194558
[TBL] [Abstract][Full Text] [Related]
14. From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies.
Fantini MC; Guadagni I
Dig Liver Dis; 2021 May; 53(5):558-565. PubMed ID: 33541800
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.
Herszényi L; Barabás L; Miheller P; Tulassay Z
Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497
[TBL] [Abstract][Full Text] [Related]
16. Possible Molecular Mechanisms by which Vitamin D Prevents Inflammatory Bowel Disease and Colitis-associated Colorectal Cancer.
Luan Z; Ma Y; Xin Y; Qian J; Wang H
Curr Med Chem; 2017; 24(9):911-917. PubMed ID: 27915990
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer.
Lynch HT; Brand RE; Locker GY
Fam Cancer; 2004; 3(3-4):229-32. PubMed ID: 15516846
[TBL] [Abstract][Full Text] [Related]
18. Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish origin.
Silverberg MS; Clelland C; Murphy JE; Steinhart AH; McLeod RS; Greenberg GR; Cohen Z; Siminovitch KA
Hum Genet; 2001 Mar; 108(3):205-10. PubMed ID: 11354631
[TBL] [Abstract][Full Text] [Related]
19. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
20. Genetic determinants associated with early age of diagnosis of IBD.
Connelly TM; Berg AS; Harris L; Brinton D; Deiling S; Koltun WA
Dis Colon Rectum; 2015 Mar; 58(3):321-7. PubMed ID: 25664710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
